Conditions: Hepatocellular Carcinoma
Keywords: Localised unresectable chemoembolization
Allocation: RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 65
Healthy volunteers: no

Brief summary:
This study will evaluate the role of everolimus in combination with local Transcatheter Arterial Chemoembolization (TACE) procedure in patients with localized unresectable Hepatocellular Carcinoma (HCC).

Detailed description:

Arms:
arm 1: everolimus 7.5mg/day by mouth + transcatheter arterial chemoembolization (TACE) arm 2: Placebo by mouth + transcatheter arterial chemoembolization (TACE)

Interventions: intervention 1: everolimus intervention 2: everolimus placebo
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: